The Prix Galien USA, a highly prestigious prize recognizing advancements in pharmaceuticals, is now also accepting nominations for this year’s contest for biotechnology and medical devices. The prize committee is full of medical luminaries and includes six Nobel Laureates in its ranks. The awards ceremony is scheduled for September 28 at the American Museum of Natural History in New York.
Prix Galien USA is now awarded in three categories that offer broad implications for future biomedical research: best pharmaceutical agent, best biotechnology product and best medical device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1998 and 2008 are eligible for nomination in 2009. This new eligibility period will permit the judges to determine both the immediate and the long-term impact these pharmaceuticals, biotechnology products and devices have had on human health and disease.
“The Prix Galien USA committee is delighted to be able to honor the impact medical devices have on human health,” said Gerald Weissmann, M.D., Prix Galien USA committee chair, research professor of medicine at New York University and editor-inchief of The FASEB Journal. “When we consider how new pharmaceuticals, biotechnology products and devices have changed our lives, it is clear that we have entered a new era ofmedical discovery.”